AQR Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Sell
527,913
-76,835
-13% -$1.84M 0.01% 1264
2025
Q4
$16.2M Sell
604,748
-16,084
-3% -$384K 0.01% 1017
2025
Q3
$13.2M Buy
620,832
+329,129
+113% +$7.78M 0.01% 979
2025
Q2
$6.29M Buy
291,703
+224,031
+331% +$4.16M 0.01% 1161
2025
Q1
$1.12M Buy
67,672
+2,492
+4% +$45.3K ﹤0.01% 1951
2024
Q4
$1.2M Buy
65,180
+28,252
+77% +$456K ﹤0.01% 1800
2024
Q3
$568K Buy
36,928
+737
+2% +$12.3K ﹤0.01% 2114
2024
Q2
$588K Sell
36,191
-11,356
-24% -$183K ﹤0.01% 1984
2024
Q1
$879K Sell
47,547
-1,700
-3% -$42.1K ﹤0.01% 1754
2023
Q4
$1.54M Buy
49,247
+1,120
+2% +$26.7K ﹤0.01% 1451
2023
Q3
$1M Buy
48,127
+1,936
+4% +$52.6K ﹤0.01% 1597
2023
Q2
$1.11M Buy
46,191
+5,805
+14% +$129K ﹤0.01% 1514
2023
Q1
$760K Sell
40,386
-5,048
-11% -$96.1K ﹤0.01% 1635
2022
Q4
$723K Buy
45,434
+5,531
+14% +$86.5K ﹤0.01% 1677
2022
Q3
$653K Sell
39,903
-7,361
-16% -$119K ﹤0.01% 1678
2022
Q2
$666K Buy
47,264
+8,296
+21% +$155K ﹤0.01% 1575
2022
Q1
$944K Buy
38,968
+11,275
+41% +$273K ﹤0.01% 1571
2021
Q4
$646K Buy
+27,693
New +$557K ﹤0.01% 1744
2021
Q2
Sell
-8,661
Closed -$223K 2214
2021
Q1
$223K Sell
8,661
-2,810
-24% -$124K ﹤0.01% 2086
2020
Q4
$613K Sell
11,471
-9,759
-46% -$484K ﹤0.01% 1716
2020
Q3
$876K Sell
21,230
-78,728
-79% -$3.4M ﹤0.01% 1481
2020
Q2
$4.84M Sell
99,958
-11,906
-11% -$572K 0.01% 799
2020
Q1
$4.73M Sell
111,864
-22,533
-17% -$928K 0.01% 803
2019
Q4
$5.75M Sell
134,397
-17,984
-12% -$782K 0.01% 918
2019
Q3
$5.48M Buy
152,381
+20,699
+16% +$628K 0.01% 948
2019
Q2
$3.52M Buy
131,682
+27,905
+27% +$713K ﹤0.01% 1083
2019
Q1
$2.79M Buy
103,777
+29,050
+39% +$678K ﹤0.01% 1198
2018
Q4
$1.21M Buy
+74,727
New +$1.45M ﹤0.01% 1440
2018
Q2
Sell
-29,525
Closed -$663K 2310
2018
Q1
$663K Sell
29,525
-7,038
-19% -$195K ﹤0.01% 1822
2017
Q4
$1.1M Sell
36,563
-2,097
-5% -$67.1K ﹤0.01% 1641
2017
Q3
$1.46M Hold
38,660
﹤0.01% 1516
2017
Q2
$1.08M Buy
38,660
+3,414
+10% +$102K ﹤0.01% 1646
2017
Q1
$1.21M Buy
+35,246
New +$1.24M ﹤0.01% 1593
2016
Q3
Sell
-15,434
Closed -$501K 2244
2016
Q2
$501K Sell
15,434
-16,751
-52% -$561K ﹤0.01% 1877
2016
Q1
$900K Sell
32,185
-5,566
-15% -$121K ﹤0.01% 1618
2015
Q4
$1.35M Buy
37,751
+22,618
+149% +$797K ﹤0.01% 1442
2015
Q3
$500K Sell
15,133
-23,486
-61% -$977K ﹤0.01% 1714
2015
Q2
$1.62M Buy
38,619
+10,845
+39% +$420K ﹤0.01% 1280
2015
Q1
$905K Sell
27,774
-6,000
-18% -$206K ﹤0.01% 1462
2014
Q4
$1.07M Sell
33,774
-3,600
-10% -$102K ﹤0.01% 1611
2014
Q3
$925K Sell
37,374
-62,000
-62% -$1.45M ﹤0.01% 1652
2014
Q2
$2.25M Buy
99,374
+72,800
+274% +$1.52M 0.01% 1230
2014
Q1
$647K Sell
26,574
-50,500
-66% -$1.28M ﹤0.01% 1915
2013
Q4
$1.93M Sell
77,074
-11,300
-13% -$267K 0.01% 1381
2013
Q3
$2.43M Buy
88,374
+8,700
+11% +$182K 0.01% 1165
2013
Q2
$1.45M Buy
+79,674
New +$1.1M 0.01% 1389

Other funds holding ACAD